VRTX Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.

NASDAQ:VRTX

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 6, 2024

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$VRTX N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
Vertex Pharmaceuticals Incorporated Loading... Loading...
Sector Name Loading... N/A

Related

BMRNBioMarin Pharmaceutical Inc.-1.4%
SRPTSarepta Therapeutics, Inc.-8.5%
SGENSeagen Inc.-0.1%
ALNYAlnylam Pharmaceuticals, Inc.2.2%
NTLAIntellia Therapeutics, Inc.-6.2%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue580M1,032M1,702M2,489M3,048M4,163M6,206M7,574M8,931M9,839M
Growth Rate-77.9%64.9%46.2%22.5%36.6%49.1%22.1%17.9%10.2%
EBITDA-611M-473M15M311M663M1,458M3,188M2,789M4,345M3,932M
EBITDA Margin-105.3%-45.8%0.9%12.5%21.8%35.0%51.4%36.8%48.7%40.0%
Net Income-739M-558M-112M263M2,097M1,177M2,712M2,342M3,322M3,620M
NI Margin-127.2%-54.1%-6.6%10.6%68.8%28.3%43.7%30.9%37.2%36.8%